High-dose intravenous vitamin C treatment for COVID-19
Adnan Erol
Abstract
COVID-19 pneumonia seems to be a lung injury caused by the hyperactivation immune effector cells. High-dose vitamin C may result in immunosuppression at the level of these effectors. Therefore, intravenous high-dose vitamin C could be safe and beneficial choice of treatment in the early stages of COVID-19.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)ImmunosuppressionPneumoniaMedicineVitaminEffectorImmune system2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)HyperactivationImmunologyInternal medicineVirologyInfectious disease (medical specialty)OutbreakDiseaseVitamin C and Antioxidants ResearchVitamin K Research StudiesVitamin D Research Studies